Live from the NIH registry
Studies recruiting near Salinas right now
Top 25 of 46 recruiting studies, sorted by proximity — each links to its official registry page
Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial
Metastatic Clear Cell Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma
Phase 3
Interventional 364 participants sought
Palo Alto Medical Foundation-Santa Cruz — Santa Cruz, California (29.6 mi)
· Sponsor: SWOG Cancer Research Network
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8
Phase 3
Interventional 3,680 participants sought
Palo Alto Medical Foundation-Santa Cruz — Santa Cruz, California (29.6 mi)
· Sponsor: National Cancer Institute (NCI)
Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer
Locally Advanced Cervical Adenocarcinoma, Locally Advanced Cervical Adenosquamous Carcinoma
Phase 3
Interventional 336 participants sought
Salinas Valley Memorial — Salinas, California (1.5 mi)
· Sponsor: National Cancer Institute (NCI)
An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)
Breast Cancer, Early Breast Cancer
Phase 3
Interventional 5,500 participants sought
Research Site — Monterey, California (15.8 mi)
· Sponsor: AstraZeneca
Prospective External Control Cohort In Patients With Newly Diagnosed Advanced or Metastatic EGFR Mutant Non-Small Cell Lung Cancer
Non Small Cell Lung Cancer
N/A
Observational 130 participants sought
Pacific Cancer Care — Monterey, California (15.8 mi)
· Sponsor: N-Power Medicine
A Prospective Registry to Enable Collection of Standardized Routine Care Oncology Patient Data
Cancer
N/A
Observational 20,000 participants sought
Pacific Cancer Care — Monterey, California (15.8 mi)
· Sponsor: N-Power Medicine
E-Mindfulness Approaches for Living After Breast Cancer
Breast Cancer, Depression
Phase 3
Interventional 402 participants sought
Salinas Valley Memorial — Salinas, California (1.5 mi)
· Sponsor: NRG Oncology
Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations
Locally Advanced Pancreatic Adenocarcinoma, Metastatic Pancreatic Adenocarcinoma
Phase 3
Interventional 94 participants sought
Palo Alto Medical Foundation-Santa Cruz — Santa Cruz, California (29.6 mi)
· Sponsor: SWOG Cancer Research Network
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas
Intracranial Meningioma, Recurrent Meningioma
Phase 2
Interventional 124 participants sought
Palo Alto Medical Foundation-Santa Cruz — Santa Cruz, California (29.6 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Lymphoma, Non-Hodgkin, Multiple Myeloma
Phase 2
Interventional 4,200 participants sought
Sutter Palo Alto Medical Foundation: Santa Cruz — Santa Cruz, California (29.6 mi)
· Sponsor: American Society of Clinical Oncology
mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
Advanced Esophageal Adenocarcinoma, Advanced Gastric Adenocarcinoma
Phase 3
Interventional 382 participants sought
Palo Alto Medical Foundation-Santa Cruz — Santa Cruz, California (29.6 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Preventing School Exclusion and Opioid Misuse: Effectiveness of the Inclusive Skill-building Learning Approach (ISLA)
Middle Schools, School Exclusion
N/A
Interventional 5,076 participants sought
Soquel Union Elementary School District — Capitola, California (26.6 mi)
· Sponsor: University of Oregon
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
Anatomic Stage II Breast Cancer AJCC v8, Early Stage Triple-Negative Breast Carcinoma
Phase 3
Interventional 1,295 participants sought
Salinas Valley Memorial — Salinas, California (1.5 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Stage I Breast Cancer
Phase 3
Interventional 1,670 participants sought
Dominican Santa Cruz Hospital — Santa Cruz, California (29.6 mi)
· Sponsor: NRG Oncology
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8
Phase 2
Interventional 66 participants sought
Palo Alto Medical Foundation-Santa Cruz — Santa Cruz, California (29.6 mi)
· Sponsor: SWOG Cancer Research Network
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8
Phase 2
Interventional 56 participants sought
Palo Alto Medical Foundation-Santa Cruz — Santa Cruz, California (29.6 mi)
· Sponsor: SWOG Cancer Research Network
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
Breast Cancer
Phase 3
Interventional 4,220 participants sought
Pacific Cancer Care - Oncology — Monterey, California (15.8 mi)
· Sponsor: Stemline Therapeutics, Inc.
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
End of Life, Cancer
N/A
Interventional 2,996 participants sought
Pacific Cancer Care — Monterey, California (15.8 mi)
· Sponsor: Stanford University
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Lung Non-Small Cell Carcinoma, Lung Non-Small Cell Squamous Carcinoma
Phase 3
Interventional 1,210 participants sought
Dominican Santa Cruz Hospital — Santa Cruz, California (29.6 mi)
· Sponsor: National Cancer Institute (NCI)
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Breast Cancer
Phase 3
Interventional 3,960 participants sought
Salinas Valley Memorial — Salinas, California (1.5 mi)
· Sponsor: NRG Oncology
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
Cardiovascular Disease
Phase 3
Interventional 15,100 participants sought
Research Site — Castroville, California (8.8 mi)
· Sponsor: AstraZeneca
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Stage III Colon Cancer
Phase 2, Phase 3
Interventional 1,912 participants sought
Salinas Valley Memorial — Salinas, California (1.5 mi)
· Sponsor: NRG Oncology
Phase II: Engagement and Clinical Impact of the Teleo Virtual Therapy Platform in Clinical Settings
Anxiety, Mood Disorders
N/A
Interventional 156 participants sought
Ohana Center for Child and Adolescent Behavioral Health — Monterey, California (15.8 mi)
· Sponsor: Stanford University
An External Control Arm Study in Non-Small Cell Lung Cancer
Non Small Cell Lung Cancer
N/A
Observational 650 participants sought
Pacific Cancer Care — Monterey, California (15.8 mi)
· Sponsor: N-Power Medicine
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
Advanced Lung Non-Squamous Non-Small Cell Carcinoma, Metastatic Lung Non-Squamous Non-Small Cell Carcinoma
Phase 3
Interventional 300 participants sought
Salinas Valley Memorial — Salinas, California (1.5 mi)
· Sponsor: National Cancer Institute (NCI)